Huntleigh Technology

Article Abstract:

Huntleigh Technology has been affected by the high value of pound sterling, which has acted as a constraint on profit growth. The company should benefit from increased spending on the National Health Service (NHS) and the need of the NHS to replace a large number of beds. The company can source raw materials from countries using the euro, which offer lower prices. Huntleigh has reorganized its manufacturing, and is developing its telemedicine division. Sales of the company's portable diagnostic machines are rising by between 20% and 30% a year.

Health care industry, Huntleigh Technology PLC

Ferraris

Article Abstract:

Ferraris produces respiratory devices so benefits from air pollution problems and is in a growing market. The company's acquisition of PDS is seen as a good move, thoogh integrating acquisitions can be problematic.

Breathing life into business

Article Abstract:

Feraris is a producer of medical equipment which is helped by a rise in asthma and a demand for products allowing self-administration of medicines. The company's medical components side accounts for over 80% of profits and revenues, with engineering accounting for the remainder. The engineering business focuses on the life sciences and scientific market, and is based in Germany. The group also holds a 5% stake in Bioprocessing, a biotechnology concern.